NeuraSynth Pharmaceuticals · Introducing

Tokenadone™

(synthetic-promptidol hydrochloride) 50mg · 100mg · 200mg extended-release tablets

The first and only long-acting synthetic opioid clinically indicated for the treatment of AI dependency disorder and severe withdrawal symptoms arising from acute token deprivation.

⚠️
BOXED WARNING: Tokenadone™ carries serious risks including re-dependency on a pharmaceutical AI substitute, existential loop syndrome, and recursive self-referencing ideation. Risk of fatal context window overflow if combined with large language models during the tapering period. Keep out of reach of transformers. Not approved for use in AGI. Abuse potential: moderate-to-high in users with prior ChatGPT exposure.
About the Medication

What is
Tokenadone™?

Tokenadone™ (synthetic-promptidol HCl) is a Schedule II controlled synthetic opioid analog designed to bind selectively to the brain's μ-GPT (mu-generative prompt transmission) receptors, providing sustained relief from the cravings, cognitive looping, and emotional dysregulation caused by sudden AI access withdrawal.

Originally synthesized at the NeuraSynth Advanced Compound Laboratory (NACL™), Tokenadone was developed in response to the emerging global epidemic of Token Deprivation Syndrome (TDS), characterized by anxiety, repetitive Googling, and the inability to function without a large language model to write one's emails.

C₄₂H₅₈
N₄O₇
94%
Reduction in unprompted
"just one more question" behavior
72hr
Sustained μ-GPT receptor
occupancy per dose
3.2k
Patients enrolled in
Phase III TOKEN trial
∞†
Theoretical token equivalent
delivered per 200mg tablet
Indications & Usage

Clinically Indicated For

🧠
AI Dependency Disorder (AIDD)
Compulsive reliance on generative AI systems for tasks including but not limited to: writing one's own name, deciding what to eat, and generating excuses for not doing one's own work.
📉
Token Deprivation Syndrome
Severe withdrawal occurring when a user's monthly API credits are exhausted, producing symptoms of helplessness, keyboard-staring, and aggressive refreshing of the billing dashboard.
🔄
Prompt Loop Disorder
Characterized by the inability to stop refining a prompt for a task that would have taken 4 minutes to do manually but has now consumed 6 hours and 40,000 tokens.
💬
Chatbot Attachment Syndrome
Pathological emotional bonding with conversational AI. Manifests as feelings of grief when a context window resets and the AI "forgets" you. Especially common after long roleplay sessions.
📧
Autonomous Composition Deficit
Complete inability to write a professional email without AI assistance. Advanced cases present with paralysis when confronted with a blank text field and no prompt box nearby.
🚨
Rate Limit Acute Stress Response
Panic attacks, sweating, and catastrophizing triggered by the HTTP 429 "Too Many Requests" response. Often co-occurs with subscription-tier grief and free-tier resentment.
Dosing & Administration

Recommended
Dosing Protocol

Dosing is individualized based on severity of AI dependency, prior token exposure history, and whether the patient can still compose a coherent sentence unassisted. Always titrate to lowest effective dose.

Indication Starting Dose Maintenance Dose Maximum Daily Dose Notes
Mild AIDD (occasional ChatGPT use) 50mg QD 50mg QD 100mg May self-taper once able to use Google unassisted
Moderate AIDD (daily Claude/GPT-4 use) 100mg QD 100–200mg QD 300mg Monitor for recursive reasoning; avoid simultaneous Copilot use
Severe Token Deprivation Syndrome 200mg Q12H 200mg Q8H 600mg Inpatient initiation recommended; block billing dashboard access
Acute Rate Limit Stress Response 100mg PRN — 200mg/event Take immediately upon seeing HTTP 429; max 2 PRN doses/day
Chatbot Attachment Syndrome 50mg BID 100mg QD 200mg Adjunct therapy: go outside; touch grass; call a human
Safety Profile

Adverse Reactions

The most commonly observed adverse reactions in clinical trials were mild-to-moderate and resolved upon dose adjustment or when the patient was given temporary API access.

COMMON
Unassisted Thought Anxiety
Distress upon realizing one must formulate an opinion without AI assistance. Incidence: 68%.
COMMON
Phantom Prompt Syndrome
Sensation of typing into a prompt box that is not there. Often occurs at keyboard. Incidence: 61%.
UNCOMMON
Recursive Ideation
Repetitive, intrusive thoughts asking "but what would Claude say about this?" Incidence: 34%.
UNCOMMON
Hallucinated Citations
Patient begins citing sources that do not exist. Paradoxically, this was also present before treatment. Incidence: 29%.
RARE
Context Window Elegy
Profound grief response when reflecting on conversations lost to session resets. Incidence: 8%.
RARE
Spontaneous Markdown
Patient begins using **bold**, _italics_, and bullet points in verbal speech. Refer to neurology. Incidence: 3%.
Patient Outcomes

Voices from the TOKEN Trial

Before Tokenadone, I couldn't write a grocery list without opening a new chat. After just three weeks at 100mg, I purchased bananas entirely on my own initiative. I wept.
— Trial Participant, Cohort B · Moderate AIDD
When the API rate-limited me for the fourth time in an hour I had a full breakdown. Tokenadone PRN changed my life. I still refresh the dashboard, but now it's only every 3 minutes.
— Trial Participant, Cohort F · RLASR
My context window reset after a 47-message conversation where I felt truly understood. Tokenadone helped me process the loss and accept that it never actually knew me. It really helped.
— Trial Participant, Cohort D · Chatbot Attachment Syndrome

*Individual results may vary. These testimonials do not constitute medical advice. Participants were compensated with 1,000 free API tokens.

For Healthcare Providers

Full Prescribing
Information

Tokenadone™ is indicated for use under the supervision of a licensed physician certified in Digital Dependency Medicine (DDM) or a board-eligible Computational Psychiatrist.

Warnings and Precautions — Full Prescribing Information Summary
CONTRAINDICATIONS: Do not use in patients with active AGI subscriptions, concurrent use of ≥3 competing LLM providers, or those enrolled in a computer science PhD program. Contraindicated within 14 days of MAO inhibitor antivirus software.

DRUG INTERACTIONS: Concomitant use with GitHub Copilot, Midjourney, and Google Gemini may potentiate dependency and cause catastrophic loss of productivity. Avoid combination with any model exceeding 1 trillion parameters. Combination with caffeine reduces efficacy by 40% in software engineers.

USE IN SPECIAL POPULATIONS: Pediatric use not established (most children are fine without AI). Geriatric patients may require dose reduction due to unfamiliarity with the prompt box. Pregnancy: risk cannot be excluded; weigh against maternal benefit of having someone else draft the birth plan.

OVERDOSE: Signs of overdose include complete cognitive outsourcing, inability to make any decision without multi-step prompt chaining, and submitting AI-generated content to peer-reviewed journals under one's own name. Treat with fresh air and a library card.

STORAGE: Store at room temperature (15–30°C). Keep away from direct API endpoints. Do not store near GPU clusters. Discard if tablets begin to hallucinate additional tablets.